SCHEMBL9857423

SCHEMBL9857423

COC(=O)COC/C=C/c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.47
PAM P19021 1/20 0.47
NPC1 O15118 3/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
POLB P06746 1/20 0.44
MAOB P27338 1/20 0.44
PTGS2 P35354 1/20 0.43
CYP4F2 P78329 1/20 0.43
CYP4A11 Q02928 1/20 0.43
RAB9A P51151 1/20 0.43
ALDH1A1 P00352 1/20 0.43
MMP1 P03956 1/20 0.43
MMP2 P08253 1/20 0.43
MMP9 P14780 1/20 0.43
MMP12 P39900 1/20 0.43
ALOX5 P09917 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7366215 0.89 IDO1 (0.47) IDO1PAMNPC1MEN1KMT2A
SCHEMBL7366213 0.89 IDO1 (0.47) IDO1PAMNPC1MEN1KMT2A
SCHEMBL10510400 0.83 PAM (0.58) IDO1PAMMAOBALDH1A1MMP1
SCHEMBL9857863 0.83 PAM (0.58) IDO1PAMMAOBALDH1A1MMP1
SCHEMBL18444843 0.83 IDO1 (0.46) IDO1PAMNPC1MEN1KMT2A
SCHEMBL22064200 0.81 NPC1 (0.47) IDO1NPC1MEN1KMT2ARAB9A
SCHEMBL22063783 0.81 IDO1 (0.45) IDO1PAMNPC1MEN1KMT2A
SCHEMBL9203671 0.81 NPC1 (0.53) NPC1MEN1KMT2APOLBMAOB
SCHEMBL9203661 0.81 NPC1 (0.53) NPC1MEN1KMT2APOLBMAOB
SCHEMBL15315162 0.81 IDO1 (0.47) IDO1PAMNPC1POLBMMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0301401-B1 LEUKOTRIENE ANTAGONISTS, PROCESS FOR THEIR PREPARATION, THEIR USE IN THE TREATMENT OF ILLNESSES HOECHST AKTIENGESELLSCHAFT (DE) 1991-11-27 EP disclosed
EP-0301401-A2 Leukotriene antagonists, process for their preparation, their use in the treatment of illnesses HOECHST AKTIENGESELLSCHAFT (DE) 1989-02-01 EP disclosed